Hy­dropothe­cary breaks ground on green­house ex­pan­sion

Stockwatch Daily - - CONSUMER GOODS - Mr. Se­bastien St-Louis re­ports

THE HY­DROPOTHE­CARY Corp. has of­fi­cially bro­ken ground on its 250,000square-foot green­house ex­pan­sion. When com­pleted, the $25-mil­lion build­ing will cre­ate an ad­di­tional 100 full-time jobs with ben­e­fits at the Hy­dropothe­cary’s fa­cil­ity in Gatineau, Que., bring­ing the com­pany’s to­tal em­ploy­ment to over 200 peo­ple.

The ex­pan­sion will bring to­tal pro­duc­tion ca­pac­ity to 300,000 square feet, al­low­ing Hy­dropothe­cary to pro­duce 25,000 kilo­grams of dried cannabis an­nu­ally. This phase of the com­pany’s ex­pan­sion has been fully fi­nanced by past fi­nanc­ings.

“With this ex­pan­sion of our pro­duc­tion ca­pac­ity, we are boldly sig­nalling our in­tent to not only ex­pand our well-es­tab­lished pres­ence in the med­i­cal mar­i­juana mar­ket, but to be­come a ma­jor player in the le­gal adult-use recre­ational mar­ket,” said Se­bastien St-Louis, Hy­dropothe­cary’s chief ex­ec­u­tive of­fi­cer and co-founder.

Hy­dropothe­cary was re­cently awarded the Coup de Coeur at the Quebec Job Cre­ation Awards Gala held in Quebec City on Oct. 4, 2017. The awards are given an­nu­ally to hon­our ma­jor job cre­ators in Quebec and its 17 ad­min­is­tra­tive re­gions.

“As Quebec’s only li­censed pro­ducer of cannabis, we are proud of our con­tri­bu­tion to Quebec’s econ­omy and we look for­ward to col­lab­o­rat­ing with govern­ment de­ci­sion mak­ers on the de­vel­op­ment of a safe, reg­u­lated cannabis in­dus­try which re­sponds to the health and se­cu­rity con­cerns of Que­beck­ers,” added Mr. St-Louis.

The ground­break­ing cer­e­mony was at­tended by sev­eral dig­ni­taries, em­ploy­ees and mem­bers of the com­mu­nity.

About The Hy­dropothe­cary Corp.

Hy­dropothe­cary is an au­tho­rized li­censed pro­ducer and dis­trib­u­tor of med­i­cal cannabis li­censed by Health Canada un­der the Ac­cess to Cannabis for Med­i­cal Pur­poses Reg­u­la­tions (Canada). In ad­di­tion to med­i­cal cannabis pro­duc­tion and sales, Hy­dropothe­cary explores var­i­ous re­search and de­vel­op­ment op­por­tu­ni­ties for cannabi­noid ex­tracts, drugs and com­bi­na­tory chem­istry. In ad­di­tion, the com­pany is in­ves­ti­gat­ing the de­vel­op­ment and patent­ing of novel tech­nolo­gies re­lated to med­i­cal cannabis, as well as the im­port and ex­port of med­i­cal cannabis.

Nathalie Bourque, Vin­cent Chiara, Ja­son Gor­don Ewart, Adam Miron, Michael Ross Mun­zar, Se­bastien St-Louis

(THCX) Shares: 76,644,886

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.